AbTis Wins U.S. Patent Ruling, Safeguarding Core Rights to AbClick Platform
Antibody-drug conjugate developer AbTis announced on August 14 that it has prevailed in an inter partes review before the U. S.
Search results for "subsidiary"
Exclusive: Boryung’s Spun-Off Sales Unit Sets Pay Above Parent Levels, Top 40% Eligible for 100 Million-Plus Won
Boryung is setting compensation at its soon-to-be spun-off prescription drug sales division above parent-company levels, establishing an aggressive...
Moderna’s Landmark mRNA Cancer Vaccine Phase 3 Success Spotlights Korean Biotech Ties
Positive late-stage clinical results for a personalized messenger RNA cancer vaccine developed by Moderna and Merck are...
Celltrion Chairman Seo Jung-jin Forgoes Summer Vacation for Global Business Tour Targeting Record Second Half
Celltrion Group Chairman Seo Jung-jin will forgo his summer vacation this August to embark on an intensive overseas...
South Korea Ranks in GSK’s Global Top 10 for Clinical Research, with Over 70 Trials Underway
"South Korea is among the top 10 markets in GSK’s global clinical research. More than 70 clinical programs are...
Ilyang Pharmaceutical Commits 17.6 Billion Won to China Comeback with Flagship Wonbi-D
Ilyang Pharmaceutical is mounting a fresh push into the Chinese market, reviving a business operation that had been...
HLB Innovation Expands Phase 1 CAR-T Trial Following Clean Early Safety Data
HLB Innovation announced on July 23 that its U.S. subsidiary, Verismo Therapeutics, has expanded the Phase 1 clinical...
Resetting the Body Clock: Smartphone App Cuts Mood Disorder Relapse Rates to One-Third
"I’m taking my medication faithfully—so why is this happening again?" It is a deeply frustrating question that patients...
SCL Healthcare Secures U.S. Patent for Genetic Test Predicting Metabolic Syndrome Risk
SCL Healthcare has successfully secured a U.S. patent for a novel genetic testing technology designed to predict an...
Will a 'Second Gleevec' Emerge? The Race Heats Up for Rare Gastrointestinal Cancer Breakthroughs
A rare cancer can form in the wall of the stomach or intestines: gastrointestinal stromal tumor, or GIST.